{
  "ptid_time": "135_S_5015_2012-11-13",
  "img_path": "/data/qiuhui/data/adni/images/135_S_5015/2012-11-13/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 43,397 mm³, 54.6% above the reference mean. With a Z-score of 1.25 (89.4th percentile), this represents mild enlargement; hippocampal volume measures 6,178 mm³, 13.2% below the reference mean. With a Z-score of -1.21 (11.4th percentile), this represents mild atrophy; whole brain volume measures 954,137 mm³, 2.1% below the reference mean. With a Z-score of -0.26 (39.6th percentile), this represents normal volume ; entorhinal cortex volume measures 2,518 mm³, 31.4% below the reference mean. With a Z-score of -1.93 (2.7th percentile), this represents moderate atrophy; fusiform gyrus volume measures 16,549 mm³, 2.7% below the reference mean. With a Z-score of -0.25 (40.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 15,275 mm³, 20.3% below the reference mean. With a Z-score of -1.76 (3.9th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 77.8 years. Gender is Female. Education: 14 years. Handedness: Right. Race: Black or African American. Medical history: Cardiovascular; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal. MMSE: 23.0. MoCA: 15.0. Logical Memory: 2.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.65 SUVR (profound elevated); Amyloid beta: 783.50 pg/mL (normal ); Total tau: 284.30 pg/mL (normal ); Phosphorylated tau: 28.64 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the entorhinal cortex and middle temporal gyrus, along with mild hippocampal atrophy, which are hallmark regions for Alzheimer's pathology. Despite normal Aβ and tau biomarkers, the profound AV45 (amyloid PET) elevation suggests amyloid deposition, and the cognitive scores (MMSE 23, MoCA 15) indicate moderate impairment.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease, amyloid-positive, biomarker-discrepant variant)**  \n**Confidence:** **Medium** (due to conflicting biomarkers—normal CSF Aβ/T-tau/P-tau but elevated AV45—though imaging and cognitive deficits strongly support neurodegeneration)",
  "timestamp": "2025-07-26T15:47:15.022053"
}